The store will not work correctly when cookies are disabled.
2-(8-hydroxyquinolin-2-yl)-3-(4-(trifluoromethyl)phenyl)thiazolidin-4-one
ID: ALA4795438
PubChem CID: 162672682
Max Phase: Preclinical
Molecular Formula: C19H13F3N2O2S
Molecular Weight: 390.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CSC(c2ccc3cccc(O)c3n2)N1c1ccc(C(F)(F)F)cc1
Standard InChI: InChI=1S/C19H13F3N2O2S/c20-19(21,22)12-5-7-13(8-6-12)24-16(26)10-27-18(24)14-9-4-11-2-1-3-15(25)17(11)23-14/h1-9,18,25H,10H2
Standard InChI Key: BYIZWYFMSVYKJA-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
19.8258 -2.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8246 -3.0482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5327 -3.4572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5309 -1.8198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2395 -2.2251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2403 -3.0441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9488 -3.4511 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6571 -3.0403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6523 -2.2182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9432 -1.8148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5346 -4.2744 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3705 -3.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4591 -4.2557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2591 -4.4225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6650 -3.7131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1157 -3.1081 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.8556 -4.8023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0768 -4.5512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4720 -5.0996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6448 -5.8992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4278 -6.1475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0292 -5.5974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5944 -5.1677 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0403 -6.4492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2618 -6.2008 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.2144 -7.2477 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.4545 -7.0245 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
8 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
14 23 2 0
20 24 1 0
24 25 1 0
24 26 1 0
24 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 390.39 | Molecular Weight (Monoisotopic): 390.0650 | AlogP: 4.74 | #Rotatable Bonds: 2 |
Polar Surface Area: 53.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.30 | CX Basic pKa: 3.46 | CX LogP: 4.14 | CX LogD: 4.14 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.69 | Np Likeness Score: -0.94 |
References
1. Bhat SY,Jagruthi P,Srinivas A,Arifuddin M,Qureshi IA. (2020) Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1., 186 [PMID:31759728] [10.1016/j.ejmech.2019.111860] |